Publications

Filter by year

Filter by type

Filter by year

Showing all years

Entwicklung neuer Messinstrumente zur Erfassung von Cumulative Life Course Impairments (CLCI) bei chronisch-entzündlichen Hautkrankheiten

C. Braren-von Stülpnagel, M. Augustin, L. Westphal, R. Sommer

Poster presented at the 52. Jahrestagung der Deutschen Dermatologischen Gesellschaft (DDG-Tagung), Berlin, Germany.

Psychosocial health and quality of life in ICSI and naturally conceived adolescents: a cross-sectional comparison

N. Eisemann, M. Schnoor, E. Rakuska, C.C. Braren-von Stülpnagel, A. Katalinic, M. Ludwig, B. Sonntag, A.K. Ludwig & S.A. Elsner

Psychosocial health (PH) and quality of life (QoL) are important health outcomes. We compared PH and QoL of adolescents conceived with intrazytoplasmatic sperm injection (ICSI) and of naturally conceived controls. The impact of disclosure of ICSI-conception on QoL and PH was quantified.

PMID:
36928650
DOI:
https://doi.org/10.1007/s11136-023-03382-5

Associations between disease burden and mental health outcomes in male and female patients with anogenital psoriasis: the mediating role of social avoidance and cognitive distraction coping

N. da Silva, M. Augustin, R. Sommer

Poster presented at the EADV Congress 2023, Berlin, Germany.

Development of Measurement Tools to Assess Cumulative Life Course Impairment in Patients with Chronic Skin Diseases

C.C. Braren-von Stülpnagel, M. Augustin, L. Westphal, R. Sommer

Patients with chronic skin diseases suffer from physical, psychological, emotional and social impairments. The overall burden has significant impact on patients' life, contributing to irreversible damage across many domains, known as cumulative life course impairment (CLCI). The aim of this project was to develop instruments which (a) measure persisting CLCI and (b) identify patients at risk for developing future CLCI.

PMID:
36807404
DOI:
https://doi.org/10.1111/jdv.18977

Effectiveness of a Structured Short Intervention Against Stigmatizing Attitudes Towards People with Skin Diseases in Body Care Professions

J. Traxler, M. Augustin, M. Grosser, C. Braren-von Stülpnagel, R. Sommer

Poster presented at the EADV Congress 2023, Berlin, Germany.

Development of an online-intervention to prevent self-stigmatization in people with visible chronic skin diseases

R. Sommer, CFZ. Stuhlmann, N. da Silva, J. Traxler

Poster presented at the EADV Congress 2023, Berlin, Germany

Exploring the burden of xerosis cutis and the impact of dermatological skin care from patient's perspective

R. Sommer

Poster presented at the 52. Jahrestagung der Deutschen Dermatologischen Gesellschaft (DDG-Tagung), Berlin, Germany.

Patient-reported Well-being in Value-based Care Using Tildrakizumab in a Real-world Setting: Protocol of a Multinational, Phase IV, 1-cohort Prospective Observational Study (the POSITIVE Study)

M. Augustin, R. Sommer, E. Daudén, P. Laws, E. de Jong, G. Fabbrocini, L. Naldi, A. Navarini, J. Lambert, Z. Reguiai, S. Gerdes, E. Massana, T. Obis, I. Kasujee, U. Mrowietz

Psoriasis is a chronic inflammatory skin disease that negatively impacts the quality of life of patients and their families. However, the most commonly used decision-making tools in psoriasis, Psoriasis Area and Severity Index (PASI), Physician Global Assessment (PGA) and Dermatology Life Quality Index (DLQI), do not fully capture the impact of psoriasis on patients' lives. In contrast, the well-established 5-item WHO Well-being Index (WHO-5) assesses the subjective psychological well-being of patients. Moreover, while drug innovations became available for psoriasis, data on the impact of these therapies on patients' lives and their closest environment (family, physicians) are limited. This study will assess the effect of tildrakizumab, an interleukin-23p19 inhibitor, on the overall well-being of patients with moderate-to-severe psoriasis. Moreover, the long-term benefit of tildrakizumab on physicians' satisfaction and partners' lives of patients with psoriasis will be evaluated.

PMID:
36792337
DOI:
https://doi.org/10.1136/bmjopen-2021-060536

Disease burden and patient-defined treatment needs and benefits in patients with psoriasis with and without anogenital involvement

N. da Silva, M. Augustin, D. Wilsmann-Theis, A. Tsianakas, P. Staubach-Renz, R. Sommer

Poster presented at the EADV Congress 2023, Berlin, Germany.

Identifying Predictors and Correlates of Skin Disease Self-Stigma for Online RCT Intervention: A systematic review

CFZ. Stuhlmann, J. Traxler, V. Paucke, R. Sommer

Poster presented at the 52. Jahrestagung der Deutschen Dermatologischen Gesellschaft (DDG-Tagung), Berlin, Germany.

<< < 1 … 4 5 6 7 8 … 23 > >>